Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Organogenesis Holdings Inc shares valued at $413,625 were purchased by Freedman Lori on Jun 05 ’25. At $2.91 per share, Freedman Lori acquired 142,379 shares. The insider’s holdings grew to 837,437 shares worth approximately $2.74 million following the completion of this transaction.
Also, Freedman Lori purchased 100,863 shares, netting a total of over 284,716 in proceeds. Following the buying of shares at $2.82 each, the insider now holds 695,058 shares.
Before that, Freedman Lori had added 9,022 shares to its account. In a trade valued at $26,949, the Chief Admin. and Legal Officer bought Organogenesis Holdings Inc shares for $2.99 each. Upon closing the transaction, the insider’s holdings increased to 9,022 shares, worth approximately $2.77 million.
As published in their initiating research note from Lake Street on June 28, 2024, Organogenesis Holdings Inc [ORGO] has been a Buy and the price target has been revised to $5. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in early February. As of June 15, 2023, Morgan Stanley has initiated its “an Equal-weight” rating for ORGO. Earlier on May 24, 2023, BTIG Research upgraded its rating. Their new recommendation was “a Buy” for ORGO stock which previously was a “a Neutral”.
Analyzing ORGO Stock Performance
On last trading session,, Organogenesis Holdings Inc [NASDAQ: ORGO] rose 4.47% to $3.27. The stock’s lowest price that day was $3.08, but it reached a high of $3.31 in the same session. During the last five days, there has been a surge of approximately 0.62%. Over the course of the year, Organogenesis Holdings Inc shares have jumped approximately 2.19%. Shares of the company reached a 52-week high of $6.71 on 03/03/25 and a 52-week low of $2.61 on 06/03/25.
Support And Resistance Levels for Organogenesis Holdings Inc (ORGO)
According to the 24-hour chart, there is a support level at 3.13, which, if violated, would cause prices to drop to 2.99. In the upper region, resistance lies at 3.36. The next price resistance is at 3.45. RSI (Relative Strength Index) is 49.30 on the 14-day chart, showing neutral technical sentiment.
Is Organogenesis Holdings Inc subject to short interest?
Stocks of Organogenesis Holdings Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.27 million shares to 11.49 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 11.77 million shares. A decline of -2.39% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.79 of the overall float, the days-to-cover ratio (short ratio) decline to 6.79.
Which companies own the most shares of Organogenesis Holdings Inc (ORGO)?
In terms of Organogenesis Holdings Inc share price expectations, FactSet research, analysts set an average price target of 6 in the next 12 months, up nearly 91.69% from the previous closing price of $3.13. Analysts anticipate Organogenesis Holdings Inc stock to reach 6 by 2025, with the lowest price target being 6. In spite of this, 3 analysts ranked Organogenesis Holdings Inc stock as Buy at the end of 2025.
